Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ObsEva
ObsEva
In ObSeva's latest attempt to stay afloat, the Swiss biotech offloads one of 2 remaining assets
Fierce Biotech
Tue, 11/22/22 - 11:02 am
ObsEva
ebopiprant
preterm labor
BioSpace Layoff Tracker 2022: Cyclerion, OncoSec Implement Restructuring Initiatives
BioSpace
Fri, 10/7/22 - 10:45 am
layoffs
Cyclerion
OncoSec
Exicure
AbbVie
Bristol Myers Squibb
Palisade Bio
ObsEva
Rubius Therapeutics
Novartis
Finch Therapeutics
ObsEva will cut staff by 70% after FDA setback for uterine fibroids candidate linzagolix
Fierce Pharma
Tue, 09/13/22 - 07:53 pm
ObsEva
uterine fibroids
linzagolix
layoffs
FDA setback leads women’s health biotech ObsEva to give up on uterine fibroids drug
MedCity News
Wed, 07/27/22 - 06:43 pm
ObsEva
uterine fibroids
linzagolix
FDA
ObsEva files uterine fibroid drug in US, chasing AbbVie, Myovant
Pharmaforum
Wed, 09/15/21 - 10:46 am
ObsEva
uterine fibroids
AbbVie
Myovant
FDA
linzagolix
Merck women's health spinout Organon bags preterm labor drug ahead of phase 3
Fierce Biotech
Tue, 07/27/21 - 10:33 am
ObsEva
Organon
Merck
preterm labor
ebopiprant
Obseva shows why red flags are worth heeding
EP Vantage
Tue, 07/7/20 - 10:26 am
ObsEva
uterine fibroids
clinical trials
linzagolix
Lilly, Galapagos halt trials as coronavirus deepens impact on drug research
BioPharma Dive
Mon, 03/23/20 - 12:00 pm
Eli Lilly
Galapagos
ObsEva
clinical trials
COVID-19
Upcoming events – Fibroid data for Obseva, as Inventiva turns to Nash
EP Vantage
Fri, 03/6/20 - 10:49 am
ObsEva
uterine fibroids
clinical trials
NASH
Inventiva
lanifibranor
Upcoming events – Obseva's first fibroid foray and Newron's test in Retts
EP Vantage
Fri, 09/6/19 - 10:12 am
clinical trials
ObsEva
uterine fibroids
linzagolix
Newron Pharma
Rett Syndrome
The Week Ahead In Biotech: Pending Clinical Readouts In Focus
Yahoo/Benzinga
Mon, 07/1/19 - 10:32 am
Retrophin
Karyopharm
Celyad
uniQure
Sangamo Therapeutics
Catalyst Biosciences
Novo Nordisk
Reata Pharmaceuticals
Vertex Pharmaceuticals
Bellicum
Gilead Sciences
Jaguar Health
TRACON Pharmaceuticals
FibroGen
Aslan Pharma
ObsEva
Sorrento Therapeutics
Biopharma IPOs sluggish in Q1. Will that continue?
BioPharma Dive
Thu, 04/13/17 - 06:41 pm
IPOs
AnaptysBio
Jounce Therapeutics
ObsEva
Valeritas
Biotech IPOs off to better start in 2017
BioPharma Dive
Fri, 02/3/17 - 10:12 am
biotech
IPOs
ObsEva
AnaptysBio
Jounce Therapeutics
Women’s health biotech ObsEva sets terms for $87M IPO
Fierce Biotech
Wed, 01/18/17 - 10:01 am
IPOs
ObsEva
Women's Health